Cellular Technology Limited

Cellular Technology Limited (CTL) specializes in cell mediated immune monitoring for research, pre-clinical and clinical trials. CTL develops and validates test methods in various test systems, tailored to the client’s needs. Specializing in high-throughput ELISPOT, CTL also performs multiplex bead array, ELISA, FACS, CBA, etc.. CTL serves as a central blood processing site, separating and cryopreserving PBMC from whole blood (from human and other diverse animal species). CTL also provides logistic set up, site training, and support throughout the world.

CTL has been providing contract laboratory services for government laboratories, major pharmaceutical companies, biotechnology companies, and academic institutions for nearly 20 years. Our company has been recognized by the Cancer Vaccine Consortium as its ELISPOT reference laboratory and has been awarded a contract by the US National Institutes of Health (NIH) to validate the ELISPOT assay from preclinical and clinical trials.